EUPRAXIA PHARMACEUTICALS INC.
EPRXPharmaceutical Preparations · SIC 2834 · CIK 0001581178
Revenue FY2025
$0.0M
Net Income
$(39.0M)
EPS (Basic)
$-1.03
Net Margin
—
ROE
-47.0%
Total Equity
$82.0M
Shares Out
36M
EUPRAXIA PHARMACEUTICALS INC. — Pharmaceutical Preparations. Figures are as reported in each year's original 40-F (foreign private issuer annual report) via SEC EDGAR XBRL company facts (FY2022–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 2 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Vivo Capital
Vivo Capital
$8.9M
0.1%
—
OrbiMed Advisors
OrbiMed Advisors
$1.8M
0.0%
NEW
Insider Transactions
Reading stored insider transactions…